GSK Florida Medicaid Deal Close; Discounts Are Not "Difficult," Garnier Says
Executive Summary
GlaxoSmithKline's discounts to the Florida state Medicaid program are not out of line with agreements with other states, CEO J.P. Garnier told the Bear Stearns "virtual" healthcare conference Sept. 24.
You may also be interested in...
GSK R&D Initiative Sees Early Success: Phase II NCEs Up Three-Fold
GlaxoSmithKline's R&D productivity program has experienced some early successes in the number of compounds coming out of the early-stage pipeline
GSK R&D Initiative Sees Early Success: Phase II NCEs Up Three-Fold
GlaxoSmithKline's R&D productivity program has experienced some early successes in the number of compounds coming out of the early-stage pipeline
Florida Medicaid In The Spotlight: GSK Error Program Is Latest Experiment
GlaxoSmithKline is expanding its formulary position in Florida's Medicaid program by implementing a medication error reduction program in lieu of supplemental rebates